ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,221 | -18.8% | 81,850 | -8.0% | 0.03% | -14.7% |
| Q2 2023 | $2,734 | -99.9% | 88,950 | -32.9% | 0.03% | -46.9% |
| Q1 2023 | $4,775,777 | +17.1% | 132,550 | +28.4% | 0.06% | +10.3% |
| Q4 2022 | $4,078,464 | -11.2% | 103,200 | -5.6% | 0.06% | 0.0% |
| Q3 2022 | $4,595,000 | -54.6% | 109,300 | -56.5% | 0.06% | +3.6% |
| Q2 2022 | $10,123,000 | +83.1% | 251,200 | +77.0% | 0.06% | +3.7% |
| Q1 2022 | $5,528,000 | +15.1% | 141,900 | +17.8% | 0.05% | +28.6% |
| Q4 2021 | $4,802,000 | +111.3% | 120,500 | +91.6% | 0.04% | +100.0% |
| Q3 2021 | $2,273,000 | -10.9% | 62,900 | +1.1% | 0.02% | -8.7% |
| Q2 2021 | $2,550,000 | -12.3% | 62,200 | -6.7% | 0.02% | -14.8% |
| Q1 2021 | $2,909,000 | +37.1% | 66,700 | +57.3% | 0.03% | +35.0% |
| Q4 2020 | $2,122,000 | – | 42,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |